Join Dr Hugh Calkins for a discussion of his groundbreaking paper: Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
You can now access the ‘Exploring re-circuit’ e-Learning immediately. Whether you missed the live club or simply wish to revisit it, click here to instantly to access the video in one of six languages:
Earn CME credits
In order to claim CME credits for watching the ‘Exploring re-circuit module’ and receive a certificate, please register on our eLearning platform. You can also access this module in 6 languages: English, German, French, Italian, Spanish and Japanese. Following a brief pre-assessment, you will be able to view the module and can subsequently take the post-assessment. Your certificate of accreditation will become available following this.
Access CME Module
Dr Hugh Calkins
John Hopkins Hospital
Catheter ablation is an antiarrhythmic surgical technique used in the treatment of atrial fibrillation. Typically, it is performed with uninterrupted anticoagulation with warfarin, or interruption of a NOAC course for a period before and following surgery. However, the results of this new study indicate that an uninterrupted course of NOACs may, in fact, be safer than other anticoagulant courses.
View abstract Access full paper
This educational activity is designed for cardiologists, surgeons, primary care physicians, GPs, nurses and any other healthcare professional with an interest or role in atrial fibrillation management.
Upon completion of this activity, participants should be able to:
- Identify factors that influence the choice and dose of oral anticoagulant in atrial fibrillation patients scheduled to receive an ablation procedure.
Professor John Camm
Advisor for: Boehringer Ingelheim, Daiichi Sankyo
Consultant (retained) for: Boehringer Ingelheim
Received honoraria from: Bayer, Daiichi Sankyo, BMS-Pfizer
Dr Hugh Calkins
Consultant for: Boehringer Ingelheim, Medtronic
Received honoraria from: Boehringer Ingelheim
Received research support from: Boehringer Ingelheim
Staff and reviewer disclosures
ACHL staff, PCM Scientific staff, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and PCM Scientific. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designated this live activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This independent educational activity is supported by funding from Boehringer Ingelheim. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme.
The activity is run at arm’s length from the financial supporter and all content is created by the faculty. No funder has had input into the content of the materials or presentations available on this website.